Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzyl benzoate emulsion versus oral ivermectin for scabies
2020-003255-15Phase 4Completed
- Sponsor
- Landeskrankenhaus Salzburg
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ivermectin and benzyl benzoate in scabies (2 arms), sponsored by Landeskrankenhaus Salzburg. Primary endpoint: Cure rate. Started Oct 2020; status: completed.
02
Drugs
ivermectinbenzyl benzoate
03
Conditions
scabies
Beyond the preview
Go deeper on 2020-003255-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003255-15.